Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Watch Best of BIO
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    Agriculture & Environment
    Addressing Climate Change
    Strengthening the Bioeconomy
    Growing Trust in Innovation
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Join Today
    Member Directory
    Have a Voice
    Membership Eligibility
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member ag&evnt
    Agriculture & Environment
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest blogs on BIOtechNOW
    Watch Best of BIO
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    Good Day BIO
    I AM BIO Podcast
    All News & Insights

    Sign up for the Good Day BIO Newsletter >

  • BIOEquality
    1. Promote

    Health equality in access to medicines and ensuring diversity in clinical trials.

    2. Invest

    In the current and next generation of black scientists and entrepreneurs.

    3. Expand

    Opportunities for women, Black and other minority populations in the growing Bio-economy.

    Learn More >
  • Events
    Event Portfolio
    Business Development
    Health
    Agriculture & Environment
    International
    Members Only
    All Events
    BIO International Convention

    June 13-16, 2022
    Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership

    Learn more
    BIO Partnering @ JPM
    BIO Patient & Health Advocacy Digital Summit

    October 27-28, 2021

    BIO Partnering at JPM
    BIO Partnering at JPM

    January 10-14, 2022
    Fostering the success of the Industry

    Evt CEO MegaMenu
    BIO CEO & Investor Conference

    February 14-17, 2022

     

    BIO Online Learning

    BIO now offers on-demand online classes that can be taken anywhere, anytime and at your own pace. BIO Member and group discounts available!

  • About
    About Us
    Learn about our mission, vision, values and priorities
    Programs & Initiatives
    Find out about BIO's programs & initiatives
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • BIO Media
    BIO Media

    Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.

    I am BIO Podcast
    Good Day BIO Newsletter
    I am BIO Video
    Join Today
Logo
Logo
Home
Search
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
Logo
Logo
Search
Explore the Blog
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
1088 Results Found

gooddaybio-cover-final
GoodDay BIO: How we can drive new cures
Day #2 of the BIO CEO & Investor Conference was all about the future. How can we ensure the workforce reflects the diverse demographics of the patients the industry serves? What does the future of biotech investment look like? How can we incentivize innovation? Here are some takeaways from …

BIO CEO and Investor Conf. Diversity and Inclusion panel
Industry Approaches for Hiring and Developing an Inclusive Workforce
Last month, the Biotechnology Innovation Organization (BIO) released the first annual report measuring diversity and inclusion in the biotech industry, with real, practical solutions for making the biotech workforce more representative of the industry’s customers and patients. During the BIO CEO …

CEO 2020 Welcome Reception
GoodDay BIO: How can we incentivize innovation? Wall Street, Washington insiders, and biotechs discuss.
We’re seeing an “extraordinary level” of biotech innovation, said BIO Chair Jeremy Levin, CEO of Ovid Therapeutics Inc., while kicking off the 22nd BIO CEO & Investor Conference on February 10th in New York. Day #1 of the conference featured discussions about the breakthrough therapies of the…

BIO CEO 2020
Election Outlook: Explaining Healthcare Policy Proposals’ Impacts on Innovation and Patients
“The promise for patients has never been better from a scientific point of view,” said BIO CEO and former Member of Congress Jim Greenwood, speaking at the 22nd BIO CEO & Investor Conference in New York. “But it’s the worst of times politically.” Specifically: There are “mountains of political…

BIO CEO & Investor Conference
Expanding the Toolkit for Fighting Solid Tumors
As the biotech industry advances scientific discovery around new tumor types and mechanisms of action, we’ve seen more than 2,000 combination trials launched to enhance PD-1/L1 checkpoint inhibitors’ effects on solid tumors. The oncology pipeline has some exciting new biotechnological approaches…

Jeremy Levin
Challenges and Opportunities in the Biotech Industry in 2020
The 22nd annual BIO CEO & Investor Forum kicked off today with a Welcome and Update on BIO's 2020 Initiatives on Behalf of the Industry given by Jeremy Levin, CEO of Ovid Therapeutics Chair of the Board of Directors of BIO. The industry was established in 1970’s during an era of bipartisan…

2009-2018 venture-investment-into-US-Companies-with-lead-novel-drug
The State of Investment and Innovation in Hypertension and Heart Failure
BIO’s Industry Analysis team has published its 5th report in a series on the innovation landscape of highly prevalent, chronic diseases. This new report [available here] reviews the state of drug development for hypertension and heart failure. As with the prior reports, the investigation into these…

BIOImpact-Tagline-FullColor
BIO World Congress Is Now BIO IMPACT
For nearly two decades, the BIO World Congress has served as a catalyst to the growth and evolution of the bioeconomy. From the conversations started in BIO One-on-One PartneringTM that have led to critical partnerships, to the emerging company presentations that spurred investment, the conference…

Tomasello
Meet Shawn Tomasello – Speaker at #BIOCEO20
As a new college graduate in the early 80’s, Shawn Tomasello knew one thing for sure. She wanted a career in an industry that would constantly change; one that would keep her on her toes; allow her to always be learning.  At a career fair during her senior year, she discovered Pfizer Laboratories…

Applying Game Theory to Negotiations
Applying Game Theory to Negotiations
Negotiating successful deals is a critical skill for biopharma companies hoping to bring their medical breakthroughs and treatment options to the patients around the globe who need them.  Along the way emerging biotechs need financial and strategic partners to help support thier efforts. While…

Pagination

  • « « First
  • ‹ ‹‹
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • › ››
  • » Last »
Explore BIO
Policy
Events
Industry Insights
About
Join Now
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO CEO & Investor Conference
BIO Impact
BIO Investor Forum
BIO Online Learning
BIO DOUBLE HELIX SPONSORS
Sanofi logo
Amgen logo
Bristol Myers Squibb
Genentech logo
Merck
BIO HELIX SPONSORS
Pfizer Inc Logo
Eli Lilly and Company
AbbVie Logo
Johnson and Johnson
Travere logo
1201 New York NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2022 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO